Maryna V. Kalichevska

Maryna V. Kalichevska

Auto-generated profile, based on publicly available information

Maryna V. Kalichevska

Dnipro State Medical University, Dnipro, Ukraine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2024 in CHILD`S HEALTH
Verified
Journal Article
Open access
PDF file
OSO.V. Shvaratska
O.V. Shvaratska
TBT.A. Bordii
T.A. Bordii
KHK.K. Hodiatska
K.K. Hodiatska
MKM.V. Kalichevska
M.V. Kalichevska
OKO.V. Klymenko
O.V. Klymenko
YVYa.V. Vilenskyi
Ya.V. Vilenskyi
Systemic autoinflammatory diseases (SAIDs) are considered dysregulation disorders of the innate immune system characterized by systemic sterile inflammation independent of infection and autoreactive antibodies or antigen-specific T cells. Autoinflammation is often mediated by inflammasomes; accordingly, inflammasomopathies and other enhanced interleukin (IL) 1 signaling syndromes represent a major classification group of SAIDs. Inflammasomes differ by the type of intracellular receptor which acts as a scaffold protein for the entire complex. Specifically, pyrin is one of the main intracellular sensor proteins that can initiate the formation of inflammasomes. This scientific review is the second in a series of publications jointly aiming to increase medical professionals’ awareness of SAIDs in children. It focuses on the current scientific understanding of pyrin inflammasomopathies which represent a significant cluster of all inflammasomopathies and other enhanced IL-1 signaling syndromes. We performed a focused search over the Web of Science, Scopus, PubMed Central®, Google Scholar databases over the past 10 years using the keywords “autoinflammatory diseases”, “autoinflammation”, “inflammasomopathies”, “pyrin”. The work presents an overview of inflammasomopathies, discusses the immunobiological features of the sensor protein pyrin and pyrin inflammasomes including cellular expression and molecular mechanisms of their activation and signal limitation. The review also presents the clinical and pathogenetic characteristics of the genetically determined pyrin inflammasomopathies and other enhanced IL-1 signaling syndromes: familial Mediterranean fever; pyrin-associated autoinflammation with neutrophilic dermatosis; mevalonate kinase deficiency; PSTPIP1-associated inflammatory diseases; periodic fever, immunodeficiency and thrombocytopenia syndrome; neonatal-onset cytopenia with dyshematopoiesis, autoinflammation, rash, and hemophagocytic lymphohistiocytosis; deficiency of IL-1 receptor antagonist; deficiency of IL-36 receptor antagonist; loss of IL-1 receptor to IL-1 receptor antagonist syndrome.

30 November 2024 in CHILD`S HEALTH
Verified
Journal Article
Open access
PDF file
OSO.V. Shvaratska
O.V. Shvaratska
MKM.V. Kalichevska
M.V. Kalichevska
OKO.V. Klymenko
O.V. Klymenko
OTO.M. Taran
O.M. Taran
YVY.V. Vilenskyi
Y.V. Vilenskyi
TMT.K. Mavropulo
T.K. Mavropulo
Systemic autoinflammatory diseases (SAIDs) are a group of inherited monogenic diseases characterized by dysregulated innate immunity leading to excessive activation of inflammatory pathways. Recently, some molecular mechanisms typical for autoinflammation have also been recognized in the pathogenesis of several autoimmune and immunodeficiency states. This scientific review aimed to systematize current ideas about autoinflammatory diseases to increase medical professionals’ awareness regarding the issue, which is significantly lower than that of other categories of immune dysfunction. We performed a focused search over the Web of Science, Scopus, PubMed Central®, Google Scholar databases over the past 10 years using the keywords “autoinflammatory diseases”, “autoinflammatory syndromes”, “autoinflammation”. The review reflects the historical evolution of scientific views on the immunopathogenesis of autoinflammation since the introduction of the concept in 1999: from the interleukin (IL)-1-centered paradigm to recognition of the significant role of other signaling pathways. Further, we discuss the place of autoinflammation in the spectrum of immunological disorders and present current scientific data on the immunobiological basis of autoinflammation. In particular, we review how the innate immune system triggers inflammation within the inflammasome, interferon and nuclear factor kappa B ­(NF-κB) signaling pathways, highlighting the role of intracellular sensor proteins, inflammasomes, gasdermin D, IL-1β, IL-18 and IL-36, ­NF-κB, tumor necrosis factor, type 1 interferons, and others. Based on the underlying molecular pathogenesis, the following classification categories of SAIDs have been suggested recently: inflammasomopathies and other enhanced IL-1 signaling syndromes, interferonopathies, relopathies, protein misfolding diseases/endoplasmic reticulum stress syndromes, other cytokine-signaling disorders and complementopathies. The review also discusses diagnostic challen­ges and presents current scientific recommendations for the diagnosis of SAIDs, highlighting the distinguishing features of the classic autoinflammatory disorders and the existing potential of diagnostic tests.

30 December 2024 in Clinical and Preventive Medicine
Verified
Journal Article
Open access
PDF file
KLKateryna Yu. Lytvyn
Kateryna Yu. Lytvyn
OKOlena A. Kushnіerova
Olena A. Kushnіerova
OSOlena V. Shevelova
Olena V. Shevelova
NINadiia А. Ivchina
Nadiia А. Ivchina
MKMaryna V. Kalichevska
Maryna V. Kalichevska
МКМарина В. Калічевська
Марина В. Калічевська
Aim. To analyze the epidemiological data on the incidence of rabies among animals and people in the Dnіpropetrovsk region, to evaluate the effectiveness of the implemented animal vaccination system, to assess the quality and timeliness of anti-rabies assistance in order to select priority areas in planning, monitoring, forecasting, and carrying out preventive measures in the implementation of the anti-rabies program. Materials and methods. The paper presents data from an analysis of statistical indicators of the State Institution “Dnipropetrovsk OCFDCAP Ministry of Health of Ukraine", Department of Animal Health and Welfare of the Department of Food Safety and Veterinary Medicine of the State Food and Consumer Service, the annual frequency of rabies epizootics and the incidence of rabies among people in the Dnіpropetrovsk region over the past 5-10 years. Also used were regulatory documents (orders, instructions, guidelines on rabies), reviews of literature and scientific articles (including foreign ones). Results. Analysis of rabies epizootic indicators reveals an unfavorable situation with rabies among animals in the Dnipropetrovsk region, which has been observed over the past four years. An analysis of rabies epizootics depending on the animal species found that in the wild, foxes are the most dangerous reservoir of lyssaviruses, and in anthropurgical foci the main danger is cats and dogs. The frequency of registration of rabies among people in Ukraine and the Dnipropetrovsk region over the past 20 years has been sporadic. The highest rates of rabies cases among humans were recorded during the second decade of the current century, with a definite downward trend in recent years. Of the total number of people who sought rabies medical care, 87,94% received a full course of rabies vaccination. Conclusions. The epidemiological situation regarding rabies epizootics in the Dnipropetrovsk region requires the continuation of the wild and domestic animal vaccination program in order to eliminate rabies foci among wild and domestic animals. The implementation of a program of combined anti-rabies care with the simultaneous use of anti-rabies vaccine and anti-rabies immunoglobulin is a positive fact for the medicine of the Dnipropetrovsk region.

28 May 2022 in CHILD`S HEALTH
Verified
Journal Article
Open access
PDF file
YBYu.K. Bolbot
Yu.K. Bolbot
TBT.A. Bordii
T.A. Bordii
SAS.V. Alifanova
S.V. Alifanova
MKM.V. Kalichevska
M.V. Kalichevska
The emergence and rapid spread of methicillin-resistant Staphylococcus aureus (MRSA) isolates in the world significantly complicated the treatment and changed the approaches to the diagnosis of staphylococcal infections in children. Staphylococcus aureus is a widespread microorganism dangerous for humans. A wide range of virulence factors the list of which is still being added allows it to quickly enter the body through damaged barriers and cause local and invasive infections, toxin-mediated diseases, as well as persist for a long time. Currently, two fundamentally different variants of MRSA are distinguished: health care-associated and community-acquired. Health care-associated MRSA are resistant to a greater number of antimicrobial agents, while community-acquired MRSA isolates are characterized by recurrent infections and a more severe course of invasive diseases. In addition, MRSA is gradually developing resistance to those antibacterial agents that were the basis of treatment for these infections, primarily clindamycin and vancomycin. All this requires global and regional monitoring of MRSA spread in different variants of staphylococcal infections and the sensitivity of the isolates found to antibiotics in order to optimize empiric and pathogen-specific antibacterial therapy. The article presents data on the activity of various antimicrobial agents against S.aureus, analyzes the available information on the prevalence of MRSA in Ukraine and the results of local monitoring for antibiotic resistance, which turned out to be unidirectional with global trends. Clinical and laboratory criteria for diagnosis of local staphylococcal infections, invasive and toxin-mediated diseases in childhood were presented. Treatment of S.aureus infections involves the necessary surgical interventions and antibacterial therapy considering current epidemiological situation on the spread of MRSA and their sensitivity to antimicrobial agents. Further studies are needed to determine the prevalence of MRSA in children in Ukraine to develop antibacterial therapy algorithms for various types of staphylococcal infections.

22 April 2025 in CHILD`S HEALTH
Verified
Journal Article
Open access
PDF file
OSO.V. Shvaratska
O.V. Shvaratska
TBT.A. Bordii
T.A. Bordii
MKM.V. Kalichevska
M.V. Kalichevska
OKO.V. Klymenko
O.V. Klymenko
OTO.M. Taran
O.M. Taran
TMT.K. Mavropulo
T.K. Mavropulo
Inflammasomopathies and other enhanced interleukin (IL)-1 signaling syndromes represent a significant cluster of systemic autoinflammatory diseases (SAIDs) which are monogenic disorders characterized by episodic spontaneous multisystemic inflammation mediated by innate immunity and resulting mainly from inappropriate activation of antigen-independent inflammatory mechanisms without production of autoantibodies. Autoinflammation is currently considered a distinct category of immune dysfunction along with autoimmunity/allergy and immunodeficiency. This scientific review is the third in a series of publications aimed at raising awareness among healthcare professionals regarding the diagnosis and management of SAIDs in children. The review highlights the immunobiological features of inflammasomes containing nucleotide-binding domain, leucine-rich repeat-containing proteins (NLRs). It also presents the clinical and pathogenetic features of the currently genetically defined NLRP3-, NLRP12-, NLRP1- and NLRC4-associated inflammasomopathies. The paper also discusses the potential of biologic-targeted therapies for inflammasomopathies which are now considered a key trend in the treatment of SAIDs and based on the molecular immunopathogenesis of the disease. Furthermore, we summarized the current experience of using available biological agents in the treatment of specific inflammasomopathies, namely agents blocking the effects of IL-1, IL-6, IL-17, IL-12/23, interferon-gamma, and tumor necrosis factor. Data were collected through a focused search over the Web of Science, Scopus, PubMed Central®, Google Scholar databases for the past 10 years using the keywords “autoinflammatory diseases”, “autoinflammation”, “inflammasomopathies”, “NLRP”, “NLRC”, “biologic therapies”.

24 June 2026 in CHILD`S HEALTH
Verified
Journal Article
Open access
PDF file
TMT.K. Mavropulo
T.K. Mavropulo
TBT.A. Bordiy
T.A. Bordiy
OSO.V. Shvaratska
O.V. Shvaratska
TPT.M. Plekhanova
T.M. Plekhanova
MKM.V. Kalichevska
M.V. Kalichevska
OTO.M. Taran
O.M. Taran
Background. The concept of safety netting in pediatrics is considered an important tool for safely completing a consultation under diagnostic uncertainty. In pediatric practice, its importance is particularly great, since early manifestations of serious diseases in children are often nonspecific, and further monitoring of the child’s condition is largely carried out by parents or guardians. In modern literature, safety netting is interpreted as a combination of clinical thinking, communication, informing about signs of deterioration, and organizing repeat visits. The purpose is to generalize and analyze modern scientific data on the concept of safety netting in pediatrics and determine its clinical and educational significance. Materials and methods. The study was conducted as a narrative literature review. The search for sources was made in the PubMed/MEDLINE, Scopus and Google Scholar databases for 2016–2026 using the following keywords: “safety netting”, “safety netting + pediatrics”, “safety netting + diagnostic uncertainty”, “safety netting + primary care”, “safety netting + medical education”, “safety netting + parent communication”. Additionally, the snowball method and analysis of some sources of grey literature were used. The selection of publications was carried out in accordance with the PRISMA 2020 principles. The qualitative synthesis included 17 sources on the clinical, communication and educational aspects of safety netting in pediatrics and primary care. Results. It was found that safety netting is a multi-component concept that includes reporting diagnostic uncertainty, informing about red flags, explaining the expected course of the disease, determining the timing and routes of repeat visit, organizing follow-up and documenting recommendations. The sources analyzed indicate that the effectiveness of safety netting depends on the clarity, specificity, individualization and comprehensibility of advice for parents, as well as on the use of written or digital support formats. It has been shown that safety netting can contribute to the rational use of antibiotics, reduce unjustified repeat visits and increase parental confidence in caring for their child. At the same time, the evidence base remains limited due to the heterogeneity of studies, the prevalence of qualitative and descriptive designs and the lack of standardized models for implementing this strategy. The educational value of safety netting as a professional competence that requires targeted formation in medical students and doctors is particularly emphasized. Conclusions. The concept of safety netting in pediatrics is an important component of clinical safety, combi­ning parent communication, management of diagnostic uncertainty and planning for further monitoring of the child. Its effectiveness depends on the quality of communication, adaptation of recommendations to a specific family and proper documentation. Given its clinical and educational significance, it is advisable to integrate safety netting principles into undergraduate and postgraduate training of physicians.